metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Most often read
Journal Information

Most often read

18750
Position statement on the use of albumin in liver cirrhosis
Graciela Castro-Narro, Carlos Moctezuma-Velázquez, Rene Male-Velázquez, Rafael Trejo-Estrada, Francisco Javier Bosques, Rosalba Moreno-Alcántar, Heriberto Rodríguez-Hernández, Aleida Bautista-Santos, ... Aldo Torre
Ann Hepatol. 2022;27:100708
18750
Open access
18326
Acid-base abnormalities and liver dysfunction
Periklis Katopodis, Efthymios M. Pappas, Konstantinos P. Katopodis
Ann Hepatol. 2022;27:100675
18326
Open access
15848
NAFLD VS MAFLD. The evidence-based debate has come. Time to change?
Diego García-Compeán, Alan Rafael Jiménez-Rodríguez
Ann Hepatol. 2022;27:100765
15848
Full text access
11302
Outcomes of liver transplantation in patients 70 years or older: a systematic review and meta-analysis
Babu Pappu Mohan, Sentia Iriana, Shahab Rasool Khan, Pradeep Yarra, Suresh Ponnada, Juan Fernando Gallegos-Orozco
Ann Hepatol. 2022;27:100741
11302
Full text access
11010
From Child-Pugh to MELD score and beyond: Taking a walk down memory lane
Andres Ruf, Melisa Dirchwolf, Richard B. Freeman
Ann Hepatol. 2022;27:100535
11010
Open access
10081
Current approaches to hepatic encephalopathy
Paulina Vidal-Cevallos, Norberto C. Chávez-Tapia, Misael Uribe
Ann Hepatol. 2022;27:100757
10081
Full text access
9724
Clinical treatment of cholangiocarcinoma: an updated comprehensive review
Alessandra Elvevi, Alice Laffusa, Miki Scaravaglio, Roberta Elisa Rossi, Raffaella Longarini, Anna Maria Stagno, Laura Cristoferi, Antonio Ciaccio, ... Sara Massironi
Ann Hepatol. 2022;27:100737
9724
Open access
7864
Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C
Pegah Golabi, James M. Paik, Katherine Eberly, Leyla de Avila, Saleh A. Alqahtani, Zobair M. Younossi
Ann Hepatol. 2022;27:100556
7864
Open access
7539
CAUSES OF DECOMPENSATION IN HOSPITALIZED CIRRHOTIC PATIENTS
A.B. Moreno-Cobos, J.L. Pérez-Hernández, B.A. Enríquez-Constantino, M.Y Carmona-Castillo, E.J. Medina-Ávalos, C.L. Dorantes-Nava, M.F. Higuera-De la Tijera
Ann Hepatol. 2022;27 Supl 2:100589.12
7539
Open access
6052
The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study
Osama Hamid, Ahmed Eltelbany, Abdul Mohammed, Khaled Alsabbagh Alchirazi, Sushrut Trakroo, Imad Asaad
Ann Hepatol. 2022;27:100727
6052
Open access
5916
Management of COVID-19 patients with chronic liver diseases and liver transplants
Xinyu Hu, Longyan Sun, Zhaoyang Guo, Chao Wu, Xin Yu, Jie Li
Ann Hepatol. 2022;27:100653
5916
Open access
5200
Hepatitis B virus genotypes and subgenotypes and the natural history and epidemiology of hepatitis B
Tania Queiroz Reuter, Michele Gomes-Gouvea, Samira Chuffi, Ulisses Horst Duque, José Americo Carvalho, Waltesia Perini, Marcello Moro Queiroz, Ingrid Marques Segal, ... João Renato Rebello Pinho
Ann Hepatol. 2022;27 Supl 1:100574
5200
Open access
4281
EncephalApp Stroop Test validation for the screening of minimal hepatic encephalopathy in Brazil
Marlone Cunha-Silva, Fernando L. Ponte Neto, Priscila S. de Araújo, Lucas V. Pazinato, Raquel D. Greca, Tirzah M.L. Secundo, Marcello R. Imbrizi, Leonardo T. Monici, ... Daniel F. Mazo
Ann Hepatol. 2022;27:100543
4281
Open access
4107
The possibility of hepatitis C reactivation in COVID-19 patients treated with corticosteroids
Somayeh Shokri, Shahab Mahmoudvand
Ann Hepatol. 2022;27:100704
4107
Open access
4058
Trends in drug prescriptions for type 2 diabetes, hypertension, and dyslipidemia among adults with non-alcoholic fatty liver disease
Toshiya Machida, Taku Obara, Makoto Miyazaki, Jun Inoue, Nariyasu Mano
Ann Hepatol. 2022;27:100699
4058
Open access
3936
Influence of genetic and environmental risk factors in the development of hepatocellular carcinoma in Mexico
Luis E. Gomez-Quiroz, Sonia Roman
Ann Hepatol. 2022;27 Supl 1:100649
3936
Open access
3876
Antibody response after a booster dose of SARS-CoV-2 vaccine in liver transplant recipients and those with chronic liver diseases
Mahak Chauhan, Ihechiluru Nzeako, Feng Li, Paul J. Thuluvath
Ann Hepatol. 2022;27:100702
3876
Open access
3843
Splenic vein embolization as a feasible treatment for patients with hepatic encephalopathy related to large spontaneous splenorenal shunts
Qiao Ke, Zhiyong Wang, Xinhui Huang, Ling Li, Weimin Wu, Linbin Qiu, Yubin Jiao, Yixing Xie, ... Wuhua Guo
Ann Hepatol. 2022;27:100725
3843
Open access
3170
Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in Germany
Wolfgang Maximilian Kremer, Simon Johannes Gairing, Leonard Kaps, Esmeralda Ismail, Vasiliki Kalampoka, Max Hilscher, Maurice Michel, Ekkehard Siegel, ... Christian Labenz
Ann Hepatol. 2022;27:100719
3170
Open access
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos